{"id":"https://openalex.org/W186453261","doi":"https://doi.org/10.1182/blood.v90.8.2939","title":"Peripheral Blood Progenitor Cell Mobilization Using Stem Cell Factor in Combination With Filgrastim in Breast Cancer Patients","display_name":"Peripheral Blood Progenitor Cell Mobilization Using Stem Cell Factor in Combination With Filgrastim in Breast Cancer Patients","publication_year":1997,"publication_date":"1997-10-15","ids":{"openalex":"https://openalex.org/W186453261","doi":"https://doi.org/10.1182/blood.v90.8.2939","mag":"186453261","pmid":"https://pubmed.ncbi.nlm.nih.gov/9376574"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v90.8.2939","doi":"https://doi.org/10.1182/blood.v90.8.2939","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.v90.8.2939","pdf_url":"https://ashpublications.org/blood/article-pdf/90/8/2939/1042033/2939.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/90/8/2939/1042033/2939.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080006341","display_name":"John A. Glaspy","orcid":"https://orcid.org/0000-0002-1800-9076","observed_orcids":["https://orcid.org/0000-0002-1800-9076"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.A. Glaspy","raw_affiliation_strings":["From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","Amgen Inc, Thousand Oaks, CA","From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","the South Texas Cancer Institute, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I161318765"]},{"raw_affiliation_string":"Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"the South Texas Cancer Institute, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055885795","display_name":"Elizabeth J. Shpall","orcid":"https://orcid.org/0000-0003-3947-4126","observed_orcids":["https://orcid.org/0000-0003-3947-4126"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E.J. Shpall","raw_affiliation_strings":["From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","Amgen Inc, Thousand Oaks, CA","From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","the South Texas Cancer Institute, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I161318765"]},{"raw_affiliation_string":"Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"the South Texas Cancer Institute, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049008168","display_name":"C.F. LeMaistre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C.F. LeMaistre","raw_affiliation_strings":["From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","Amgen Inc, Thousand Oaks, CA","From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","the South Texas Cancer Institute, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I161318765"]},{"raw_affiliation_string":"Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"the South Texas Cancer Institute, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010959578","display_name":"Robert A Briddell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R.A. Briddell","raw_affiliation_strings":["From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","Amgen Inc, Thousand Oaks, CA","From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","the South Texas Cancer Institute, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I161318765"]},{"raw_affiliation_string":"Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"the South Texas Cancer Institute, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112071335","display_name":"Dora Menchaca","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D.M. Menchaca","raw_affiliation_strings":["From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","Amgen Inc, Thousand Oaks, CA","From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","the South Texas Cancer Institute, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I161318765"]},{"raw_affiliation_string":"Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"the South Texas Cancer Institute, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001874374","display_name":"Stewart A. Turner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S.A. Turner","raw_affiliation_strings":["From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","Amgen Inc, Thousand Oaks, CA","From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","the South Texas Cancer Institute, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I161318765"]},{"raw_affiliation_string":"Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"the South Texas Cancer Institute, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001921808","display_name":"Michael Lill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Lill","raw_affiliation_strings":["From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","Amgen Inc, Thousand Oaks, CA","From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","the South Texas Cancer Institute, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I161318765"]},{"raw_affiliation_string":"Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"the South Texas Cancer Institute, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038146265","display_name":"Linnea I. Chap","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Chap","raw_affiliation_strings":["From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","Amgen Inc, Thousand Oaks, CA","From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","the South Texas Cancer Institute, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I161318765"]},{"raw_affiliation_string":"Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"the South Texas Cancer Institute, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Jones","raw_affiliation_strings":["From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","Amgen Inc, Thousand Oaks, CA","From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","the South Texas Cancer Institute, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I161318765"]},{"raw_affiliation_string":"Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"the South Texas Cancer Institute, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079300984","display_name":"M.D. Wiers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M.D. Wiers","raw_affiliation_strings":["From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","Amgen Inc, Thousand Oaks, CA","From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","the South Texas Cancer Institute, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I161318765"]},{"raw_affiliation_string":"Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"the South Texas Cancer Institute, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040769149","display_name":"William P Sheridan","orcid":"https://orcid.org/0000-0001-8320-1323","observed_orcids":["https://orcid.org/0000-0001-8320-1323"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W.P. Sheridan","raw_affiliation_strings":["From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","Amgen Inc, Thousand Oaks, CA","From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","the South Texas Cancer Institute, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I161318765"]},{"raw_affiliation_string":"Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"the South Texas Cancer Institute, San Antonio, TX","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109359659","display_name":"IK McNiece","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"I.K. McNiece","raw_affiliation_strings":["From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","Amgen Inc, Thousand Oaks, CA","From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","the South Texas Cancer Institute, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA; the Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, CO; the South Texas Cancer Institute, San Antonio, TX; and Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840","https://openalex.org/I161318765"]},{"raw_affiliation_string":"Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"From the Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"the South Texas Cancer Institute, San Antonio, TX","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":7.8766,"has_fulltext":true,"cited_by_count":142,"citation_normalized_percentile":{"value":0.98142763,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"90","issue":"8","first_page":"2939","last_page":"2951"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10176","display_name":"Mesenchymal stem cell research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/peripheral-blood-stem-cell-mobilization","display_name":"peripheral blood stem cell mobilization","score":0.9129999876022339},{"id":"https://openalex.org/keywords/stem-cell-factor","display_name":"stem cell factor","score":0.996999979019165},{"id":"https://openalex.org/keywords/filgrastim","display_name":"filgrastim","score":0.9919999837875366},{"id":"https://openalex.org/keywords/high-risk-breast-cancer","display_name":"high-risk breast cancer","score":0.8539999723434448},{"id":"https://openalex.org/keywords/cd34-cell-yield","display_name":"CD34+ cell yield","score":0.9599999785423279},{"id":"https://openalex.org/keywords/leukapheresis","display_name":"leukapheresis","score":0.7570000290870667},{"id":"https://openalex.org/keywords/hematopoietic-engraftment","display_name":"hematopoietic engraftment","score":0.8740000128746033},{"id":"https://openalex.org/keywords/high-dose-chemotherapy","display_name":"high-dose chemotherapy","score":0.6930000185966492}],"concepts":[{"id":"https://openalex.org/C2779171977","wikidata":"https://www.wikidata.org/wiki/Q3151081","display_name":"Filgrastim","level":4,"score":0.9707006216049194},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7901124954223633},{"id":"https://openalex.org/C2777371436","wikidata":"https://www.wikidata.org/wiki/Q3237071","display_name":"Leukapheresis","level":4,"score":0.6690173149108887},{"id":"https://openalex.org/C2777767877","wikidata":"https://www.wikidata.org/wiki/Q419327","display_name":"Granulocyte colony-stimulating factor","level":3,"score":0.5935694575309753},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47099965810775757},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.4521000385284424},{"id":"https://openalex.org/C201750760","wikidata":"https://www.wikidata.org/wiki/Q1896218","display_name":"Progenitor cell","level":3,"score":0.45172256231307983},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.42653128504753113},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4238084852695465},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.41860684752464294},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3297257125377655},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.3023220896720886},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.04782697558403015},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069585","descriptor_name":"Filgrastim","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001800","descriptor_name":"Blood Specimen Collection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006412","descriptor_name":"Hematopoietic Stem Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007937","descriptor_name":"Leukapheresis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017713","descriptor_name":"Platelet Transfusion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018567","descriptor_name":"Breast Neoplasms, Male","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018567","descriptor_name":"Breast Neoplasms, Male","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018952","descriptor_name":"Antigens, CD34","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D019089","descriptor_name":"Stem Cell Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019089","descriptor_name":"Stem Cell Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019650","descriptor_name":"Hematopoietic Stem Cell Mobilization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1182/blood.v90.8.2939","doi":"https://doi.org/10.1182/blood.v90.8.2939","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.v90.8.2939","pdf_url":"https://ashpublications.org/blood/article-pdf/90/8/2939/1042033/2939.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:9376574","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9376574","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1182/blood.v90.8.2939","doi":"https://doi.org/10.1182/blood.v90.8.2939","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.v90.8.2939","pdf_url":"https://ashpublications.org/blood/article-pdf/90/8/2939/1042033/2939.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8700000047683716,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4677846744","display_name":"General Clinical Research Center","funder_award_id":"M01RR000865","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G6337669417","display_name":"Hematopoietic Progenitor Cells- Cord Blood","funder_award_id":"R01CA061508","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W186453261.pdf","grobid_xml":"https://content.openalex.org/works/W186453261.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W40540718","https://openalex.org/W77032461","https://openalex.org/W133944846","https://openalex.org/W159629284","https://openalex.org/W184800828","https://openalex.org/W296057521","https://openalex.org/W344470510","https://openalex.org/W1129691885","https://openalex.org/W1526986700","https://openalex.org/W1543191049","https://openalex.org/W2004543423","https://openalex.org/W2020751729","https://openalex.org/W2037224058","https://openalex.org/W2043757585","https://openalex.org/W2063809730","https://openalex.org/W2075299924","https://openalex.org/W2088310945","https://openalex.org/W2089789644","https://openalex.org/W2125887123","https://openalex.org/W2138917119","https://openalex.org/W2168146165","https://openalex.org/W2227905504","https://openalex.org/W2280957141","https://openalex.org/W2289880349","https://openalex.org/W2300181711","https://openalex.org/W2302020344","https://openalex.org/W2343294262","https://openalex.org/W2400978456","https://openalex.org/W2407084750","https://openalex.org/W2407768420","https://openalex.org/W2413638587","https://openalex.org/W2415893299","https://openalex.org/W2417535135","https://openalex.org/W2418745023","https://openalex.org/W2470320446","https://openalex.org/W6607476746","https://openalex.org/W6720307338"],"related_works":["https://openalex.org/W1825856910","https://openalex.org/W1924642125","https://openalex.org/W2416957725","https://openalex.org/W7100681484","https://openalex.org/W1997879714","https://openalex.org/W2041724652","https://openalex.org/W2143766203","https://openalex.org/W2180688074","https://openalex.org/W2335097692","https://openalex.org/W1759071539"],"abstract_inverted_index":{"The":[0,101,179,250],"safety":[1],"and":[2,5,52,87,117,158,185,214,235,256,273],"optimal":[3,271],"dose":[4,272],"schedule":[6,274],"of":[7,20,48,80,89,104,115,181,183,224,241,252,278],"stem":[8],"cell":[9,197,233],"factor":[10],"(SCF)":[11],"administered":[12],"in":[13,28],"combination":[14,47,114,167,209,251],"with":[15,31,69,202,206,238,245,260],"filgrastim":[16,38,51,95,116,129,172,186,203,246,259],"for":[17,42,58,110,126,149,170,247,275],"the":[18,46,76,113,150,171,207,222,270,276],"mobilization":[19,277],"peripheral":[21],"blood":[22],"progenitor":[23],"cells":[24,106,147],"(PBPCs)":[25],"was":[26,73,108,267],"determined":[27],"215":[29],"patients":[30,66,91,111,174],"high-risk":[32],"breast":[33],"cancer.":[34],"Patients":[35],"received":[36,92],"either":[37,59],"alone":[39,130,173,204],"(10":[40],"microg/kg/d":[41,50,56,94,152,160,254,258],"7":[43],"days)":[44,191],"or":[45,62,189,205],"10":[49,93,123,257],"5":[53,266],"to":[54],"30":[55],"SCF":[57,65,153,161,184,229,255],"7,":[60],"10,":[61,188],"13":[63,190],"days.":[64],"were":[67,140],"premedicated":[68],"antiallergy":[70],"prophylaxis.":[71],"Leukapheresis":[72],"performed":[74],"on":[75,264],"final":[77],"3":[78],"days":[79],"cytokine":[81,208],"therapy":[82,230],"and,":[83],"after":[84,217],"high-dose":[85],"chemotherapy":[86],"infusion":[88],"PBPCs,":[90],"until":[96],"absolute":[97],"neutrophil":[98],"count":[99],"recovery.":[100],"median":[102],"number":[103],"CD34+":[105,146,196,232],"collected":[107],"greater":[109,121],"receiving":[112,128],"SCF,":[118],"at":[119],"doses":[120],"than":[122,125,169],"microg/kg/d,":[124],"those":[127],"(7.7":[131],"v":[132],"3.2":[133,176],"x":[134,156,164,177],"10(6)/kg,":[135],"P":[136],"<":[137,143],".05).":[138],"There":[139],"significantly":[141,194],"(P":[142],".05)":[144],"more":[145],"harvested":[148],"20":[151,253],"(median,":[154,162,175],"7.9":[155],"10(6)/kg)":[157,165],"25":[159],"13.6":[163],"7-day":[166],"groups":[168,200],"10(6)/kg).":[178],"duration":[180],"administration":[182],"(7,":[187],"did":[192],"not":[193],"affect":[195],"yield.":[198],"Treatment":[199],"mobilized":[201],"had":[210],"similar":[211],"hematopoietic":[212],"engraftment":[213],"overall":[215],"survival":[216],"PBPC":[218,248],"infusion.":[219],"In":[220],"conclusion,":[221],"results":[223],"this":[225],"study":[226],"indicate":[227],"that":[228],"enhances":[231],"yield":[234],"is":[236],"associated":[237],"manageable":[239],"levels":[240],"toxicity":[242],"when":[243],"combined":[244],"mobilization.":[249],"daily":[261],"apheresis":[262],"beginning":[263],"day":[265],"selected":[268],"as":[269],"PBPCs.":[279]},"counts_by_year":[{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2016-06-24T00:00:00"}